Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine as adjunctive therapy for schizophrenia negative symptoms
NCT00757978Phase 4Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jan 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in schizophrenia, sponsored by Hospital de Clínicas de Porto Alegre. Started Jan 2006; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00757978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00757978.